跳至主要内容
临床试验/JPRN-UMIN000049566
JPRN-UMIN000049566招募中Unknown

Prospective Study to Identify Efficacy, Safety, and Predictors of Tezepelumab in Severe Asthma - J-EAST

Japanese Red Cross Medical Center0 个研究点目标入组 30 人开始时间: 2022年11月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of previous administration of tezepelumab (2) Patients with serious complications such as cardiac, hepatic, or renal disease (3) Patients who are judged to be inappropriate for the subject by the physician's judgment.

研究者

相似试验

Prospective Study to Identify Efficacy, Safety, and... | 临床试验